Clinical Trials Logo

Filter by:
NCT ID: NCT01191385 Withdrawn - Clinical trials for Carcinoma, Hepatocellular

GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start

Start date: November 2010
Phase: N/A
Study type: Observational

This study is an international prospective, open-label, multi-center, non-interventional study. The protocol will allow enrollment of all patients with diagnosis of HCC in whom a decision to treat with sorafenib has not been made at time of study enrollment. All patients will be followed-up until withdrawal of consent, lost to follow-up, death, or the end of the study. Detailed information concerning the past medical/surgical history, performance status, methods of diagnosis and staging, etc. of patients with HCC will be collected, and practice patterns of the physicians involved in the care of patients with HCC under real-life conditions will be evaluated.

NCT ID: NCT01191177 Withdrawn - Liver Disease Clinical Trials

Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease

Start date: January 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to investigate the usefulness of oral fish oil(Lovaza)in normalizing liver function in patients who have parenteral nutrition associated liver disease. The investigators believe that patients who take oral fish oil will normalize liver function faster than those who do not

NCT ID: NCT01188954 Withdrawn - Seroma Clinical Trials

Doxycycline Versus Standard Care to Prevent Seroma Formation

Start date: January 2010
Phase: N/A
Study type: Interventional

A seroma is a collection of fluid other than pus or blood which forms through the division of numerous lymphatic channels, which normally drain the interstitial space under the skin. These channels become disrupted during surgical procedure and lead to seroma formation. This collection of fluid causes pressure in the local area, patient discomfort, and provides unfortunately an excellent culture medium for bacteria. Seroma development has been previously described in femoral vessel groin cannulation dissections after surgery. Conventional therapy is limited to draining the fluid, sometimes more than once, until there is full resolution of the seroma. If fluid collection recurs at the surgical site, sclerosant therapy with agents such as doxycycline. Doxycycline has been found to be a cost effective agent used as a sclerosant, which belongs to tetracycline class of antibiotics. The investigators hypothesize that prophylactic use of doxycycline at the site of femoral cannulation will prevent or minimize the area of seroma formation as compared to standard care of patients. The aim is driven towards limiting patient discomfort and visits to the clinic and to improve clinical care.

NCT ID: NCT01188889 Withdrawn - Clinical trials for Chronic Myeloid Leukemia

RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.

Start date: September 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Patients participating in this study will have a diagnosis of Chronic Myeloid Leukemia. This study will evaluate whether the addition of an investigational drug called RAD001 given together with Imatinib will better target leukemia stem cells, causing them to die. Stem cells are a small population of cells, existing primarily within the bone marrow, and are believed to be responsible for the ongoing risk of disease relapse.

NCT ID: NCT01188473 Withdrawn - Status Asthmaticus Clinical Trials

Early Noninvasive Positive Pressure Ventilation in Children With Status Asthmaticus

Start date: January 2009
Phase: Phase 1
Study type: Interventional

Status asthmaticus is recognized as a common cause of morbidity in children in the United States. In recent years, hospitalization rates have reached an all time high. This study will evaluate the safety, tolerability and clinical benefit of adding Noninvasive Positive Pressure Ventilation (NPPV)to regular care in children with moderate to moderately severe status asthmaticus.

NCT ID: NCT01188408 Withdrawn - Prostate Cancer Clinical Trials

Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer

Start date: June 2010
Phase: Phase 2
Study type: Interventional

LE-DT is a novel, proprietary delivery system of docetaxel developed by NeoPharm, Inc. Docetaxel (currently marketed as Taxotere) is an anti-microtubular network agent and is one of the most active agents in the treatment of metastatic castrate resistant prostate cancer (CRPC) and other variety of cancers. Taxotere has poor solubility and is designed to be administered with Tween 80 in ethanol. This vehicle causes acute hypersensitivity reaction. By removing toxic detergent used in Taxotere, the form of LE-DT, shows reduced toxicity and comparable therapeutic efficacy in pre-clinical study. The clinical evidence obtained from the NeoPharm Phase I study shows fewer side effects and possibly administered at higher dose to induce greater effectiveness of LE-DT. The current Phase II study is designed to accomplish the following objectives: 1. Assess the antitumor effect indicator serum prostate specific antigen (PSA) following the intravenous (IV) administration of 110 mg/m2 LE-DT every three weeks in patients with metastatic castrate resistant prostate cancer 2. To evaluate the measurable soft tissue disease response using the response evaluation criteria in solid tumor (RECIST) methodology 3. To evaluate the progression-free survival (PFS) and overall survival (OS) 4. To correlate PSA expression with tumor response 5. To evaluate the safety of LE-DT at 110 mg/m2 level, in particular peripheral neuropathy, water retention as well as myelotoxicity 6. To evaluate the quality of life (QOL)

NCT ID: NCT01186289 Withdrawn - Clinical trials for Neurocognitive Dysfunction

Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery

Start date: October 2010
Phase: N/A
Study type: Interventional

The primary aim of our prospective, randomized, double-blind interventional clinical trial is to determine the effectiveness of high dose atorvastatin therapy to reduce post operative cognitive dysfunction (POCD) in patients undergoing cardiac valve surgery. We hypothesize that therapy with high dose atorvastatin will significantly reduce the incidence and/or severity of POCD.

NCT ID: NCT01185808 Withdrawn - Chronic Sinusitis Clinical Trials

Vitamin D Supplementation in Chronic Rhinosinusitis With Nasal Polyps

VDinCRS
Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if Vitamin D supplementation improves clinical and immunologic parameters in chronic rhinosinusitis with nasal polyps.

NCT ID: NCT01184287 Withdrawn - Clinical trials for Non-Small Cell Lung Cancer

A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of the trial is to determine the rate of improvement in objective tumor response, following the addition of ranpirnase to ongoing pemetrexed—carboplatin chemotherapy, for patients with SD or PR following 2 cycles of doublet chemotherapy.

NCT ID: NCT01183741 Withdrawn - Hypertension Clinical Trials

Accuracy of Non-Invasive Blood Pressure Measurement in Adults

NIBP
Start date: September 2010
Phase: Phase 3
Study type: Observational

The purpose of this study is to compare the accuracy of the Sotera ViSi, an investigational device, to auscultation (measurement with a cuff) in determining systolic and diastolic blood pressure (BP) in adult subjects.